Shelter Pharma Limited has announced a board meeting to consider the financial results for the quarter and half-year.

The company has also scheduled an Extraordinary General Meeting at its registered office to discuss key corporate matters impacting shareholders.

These developments indicate active corporate governance and upcoming disclosures of financial and strategic decisions relevant to investors.